Skip to main content

02-07-2019 | Multiple sclerosis | Video

EAN 2019: Thalamus is key barometer of neuronal pathology in paediatric MS

Ermelinda De Meo shares her research findings suggesting thalamic damage is determined by heterogeneous pathological processes in young patients with multiple sclerosis (2:15).

Funding for this video was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.